TYPE II 3BETA HSD GENE REGULATION OF DHEAS SYNTHESIS
DHEAS 合成的 II 型 3BETA HSD 基因调控
基本信息
- 批准号:2053797
- 负责人:
- 金额:$ 15.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein DNA footprinting adrenal glands aging animal genetic material tag animal tissue dehydroepiandrosterone developmental genetics gel mobility shift assay gene expression genetic regulation genetic regulatory element genetic transcription human fetus tissue human genetic material tag human tissue life cycle molecular cloning nuclear runoff assay nucleic acid sequence polymerase chain reaction species difference steroid delta isomerase steroid hormone biosynthesis tissue /cell culture
项目摘要
Dehydroepiandrosterone and its sulfate (DHEA(S)) show a cycle of large
changes in secretion from the adrenal cortex over the life span in humans.
The secretion of these steroids is very high in the fetus, low in
childhood, high again in young adulthood, followed by a progressive age-
related decline. Dependent on age, 40-100% of local tissue androgens and
estrogens in both men and women are derived from DHEAS.
The critical regulatory point in the biosynthesis of DHEAS is 3beta-
hydroxysteroid/delta4 '5-isomerase (3beta-HSD). The low level of activity
of this enzyme in the human adrenal cortex, but not in animal glands such
as that of the cow, limits the flux of pregnenolone to A steroids, such as
cortisol, and maintains the synthesis of delta5 steroids, principally
DHEA(S). The proposed experiments will analyze the differences between the
type Il human 3beta-HSD gene, which is expressed in the adrenal cortex and
other steroidogenic tissues, and the 3beta-HSD gene expressed in the bovine
adrenal.
Transcription rates and mRNA stability will be assessed as possible causes
of the differences in 3beta-HSD expression between the bovine and human
adrenal cortex, and between the different zones of the human adrenal
cortex. The bovine 3beta-HSD gene (or genes) expressed in the adrenal
cortex will be isolated, its structure analyzed, and the tissue
distribution of its transcript determined. The difference in expression
levels between the human type Il and the bovine gene will be tested using
reporter constructs from the two genes transfected into primary human and
bovine adrenal cells. The elements in the type II human and the bovine
3beta-HSD genes responsible for tissue-specific expression and second
messenger regulation, and nuclear proteins from the adrenal cortex that
bind to these elements, will be characterized. The possible identity of
such proteins to known transcription factors will be tested. Cell culture
experiments will examine whether the cycle of DHEAS synthesis over the life
span in humans results from intrinsic changes in expression of 3beta-HSD.
The abundance in adrenocortical tissue of nuclear proteins that bind to the
regulatory elements of the type II 3beta-HSD gene will be correlated with
the cycle.
These experiments will elucidate the molecular basis for the regulation of
the human 3beta-HSD type
II gene and thereby the regulation of DHEAS synthesis. This information
will provide a basis for understanding the significance of the unique
secretion of this hormone in humans and the significance of its age-related
decline for aging and age-related diseases.
脱氢表雄酮及其硫酸盐(S))显示了一个大的循环
人类寿命中肾上腺皮质的分泌变化。
这些类固醇的分泌在胎儿中很高,低
童年,成年后再次高,随后是渐进的年龄 -
相关下降。 依赖年龄,40-100%的局部组织雄激素和
男性和女人的雌激素均来自DHEAS。
DHEAS生物合成的关键调节点是3beta-
羟基固醇/delta4'5-异构酶(3Beta-HSD)。 低水平的活动
人类肾上腺皮质中的这种酶,但在动物腺中没有这种酶
就像牛的那样,将妊娠的通量限制为类固醇,例如
皮质醇并维持Delta5类固醇的合成,主要是
DHEA(S)。 提出的实验将分析
IL型人类3Beta-HSD基因,该基因在肾上腺皮质和
其他类固醇组织和牛中表达的3Beta-HSD基因
肾上腺。
将作为可能的原因评估转录率和mRNA稳定性
牛与人之间3Beta-HSD表达的差异
肾上腺皮质,在人肾上腺的不同区域之间
皮质。 在肾上腺中表达的牛3Beta-HSD基因(或基因)
皮层将分离,分析其结构,并组织
确定其笔录的分布。 表达的差异
人类类型IL和牛基因之间的水平将使用
来自转染到原代人的两个基因的记者构造和
牛肾上腺细胞。 II型人和牛的元素
3Beta-HSD基因负责组织特异性表达和第二
Messenger调节和来自肾上腺皮质的核蛋白
与这些元素结合,将被表征。 可能的身份
将测试此类已知转录因子的蛋白质。 细胞培养
实验将检查生命中DHEAS合成的周期
人类的跨度是由3Beta-HSD表达的内在变化引起的。
核蛋白的肾上腺皮质组织的丰度,与
II型3Beta-HSD基因的调节元素将与
周期。
这些实验将阐明调节的分子基础
人类3Beta-HSD类型
II基因,从而调节DHEAS合成。 此信息
将为理解独特的意义提供基础
这种激素在人类中的分泌及其与年龄相关的重要性
衰老和与年龄有关的疾病的下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER J HORNSBY其他文献
PETER J HORNSBY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER J HORNSBY', 18)}}的其他基金
Stress resistance in neurons from primate iPS cells
灵长类 iPS 细胞神经元的应激抵抗力
- 批准号:
8572720 - 财政年份:2013
- 资助金额:
$ 15.23万 - 项目类别:
Stress resistance in neurons from primate iPS cells
灵长类 iPS 细胞神经元的应激抵抗力
- 批准号:
8720662 - 财政年份:2013
- 资助金额:
$ 15.23万 - 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
- 批准号:
8241495 - 财政年份:2011
- 资助金额:
$ 15.23万 - 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
- 批准号:
8391654 - 财政年份:2011
- 资助金额:
$ 15.23万 - 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
- 批准号:
8760300 - 财政年份:2011
- 资助金额:
$ 15.23万 - 项目类别:
Aging and Reprogramming of Somatic Cells to Pluripotency
体细胞的衰老和重编程至多能性
- 批准号:
7907777 - 财政年份:2009
- 资助金额:
$ 15.23万 - 项目类别:
相似国自然基金
天蓝色链霉菌中DNA甲基化依赖型限制系统的发现与表征
- 批准号:31170083
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
TYPE II 3BETA HSD GENE REGULATION OF DHEAS SYNTHESIS
DHEAS 合成的 II 型 3BETA HSD 基因调控
- 批准号:
2053796 - 财政年份:1994
- 资助金额:
$ 15.23万 - 项目类别:
TYPE II 3BETA HSD GENE REGULATION OF DHEAS SYNTHESIS
DHEAS 合成的 II 型 3BETA HSD 基因调控
- 批准号:
2516986 - 财政年份:1994
- 资助金额:
$ 15.23万 - 项目类别:
ACTH INDUCTION OF CYTOCHROME P450 IN ADRENAL CELLS
肾上腺细胞中细胞色素 P450 的 ACTH 诱导
- 批准号:
3228766 - 财政年份:1992
- 资助金额:
$ 15.23万 - 项目类别: